SCHEMBL10618445

SCHEMBL10618445

O=C1CCC=NN1c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.46
GAA P10253 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
PTGS1 P23219 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
CHRM1 P11229 1/20 0.44
TSHR P16473 1/20 0.44
DRD3 P35462 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SHMT2 P34897 1/20 0.41
LOX P28300 1/20 0.41
PTGS2 P35354 2/20 0.39
ALOX5 P09917 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9379275 0.81 POLB (0.30) POLB
SCHEMBL181548 0.80 MEN1 (0.47) POLBGAAMEN1KMT2APTGS1
SCHEMBL3059892 0.78 GAA (0.51) POLBGAAALDH1A1SMN1; SMN2PTGS2
SCHEMBL5309397 0.77 ALOX5 (0.48) CYP1A2MAPTSMN1; SMN2ALOX5PDE4A
SCHEMBL5997170 0.72 MGLL (0.45) GAAMEN1KMT2APTGS1ALDH1A1
SCHEMBL20703296 0.70 PDE3B (0.41) MEN1KMT2APTGS1ALDH1A1KDM4E
SCHEMBL8688176 0.70 ITGB3 (0.37) ALOX12
SCHEMBL9462156 0.69 L3MBTL1 (0.42) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL20703110 0.69 PDE3B (0.43) SHMT2
SCHEMBL20703202 0.68 GAA (0.42) GAAPTGS1MAPTSMN1; SMN2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3661917-B1 6-((3-TRIFLUOROMETHYL)PHENYL)-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER BAYER AG (DE) 2022-05-11 EP disclosed
EP-0084250-B1 6-(SUBSTITUTED PHENYL)-4,5-DIHYDRO-3-(2H)-PYRIDAZINONE COMPOUNDS AND PROCESSES FOR THEIR PREPARATION MITSUI TOATSU KAGAKU KABUSHIKI KAISHA (JP) 1988-06-22 EP disclosed
EP-0089528-B1 6-ARYL-4,5-DIHYDRO-3(2H)-PYRIDAZINONES, THEIR PREPARATION AND USE BASF Aktiengesellschaft (DE) 1987-05-27 EP disclosed
US-4544562-A 6-Aryl-4,5-dihydro-3(2H)-pyridazinones, and their use as anti-hypertensive and anti-thrombocyte agents BASF AKTIENGESELLSCHAFT (DE) 1985-10-01 US disclosed
EP-0088128-A4 ANTIINFLAMMATORY AND ANALGETIC 4-PYRIDYLPYRIDAZIN(2H)-3-ONES. DIAMOND SHAMROCK CORP (US) 1984-04-06 EP disclosed
EP-0089528-A1 6-Aryl-4,5-dihydro-3(2H)-pyridazinones, their preparation and use BASF Aktiengesellschaft (DE) 1983-09-28 EP disclosed
EP-0088128-A1 ANTIINFLAMMATORY AND ANALGETIC 4-PYRIDYLPYRIDAZIN(2H)-3-ONES DIAMOND SHAMROCK CORPORATION (US) 1983-09-14 EP disclosed
WO-1983000863-A1 ANTIINFLAMMATORY AND ANALGETIC 4-PYRIDYLPYRIDAZIN(2H)-3-ONES DIAMOND SHAMROCK CORP (US) 1983-03-17 WO disclosed
EP-0018063-B1 PYRIDAZIN (2H)-3-ONES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN ANTIHYPERTENSIVE AGENTS DIAMOND SHAMROCK CORPORATION (US) 1983-02-23 EP disclosed
US-4238490-A Antihypertensive pyridazin(2H)-3-ones DIAMOND SHAMROCK CORPORATION (US) 1980-12-09 US disclosed
EP-0018063-A1 Pyridazin (2H)-3-ones, process for their preparation and their use in antihypertensive agents DIAMOND SHAMROCK CORPORATION (US) 1980-10-29 EP disclosed